Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07232758 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety, Tolerability and Pharmacokinetic Studies of HRS-2183 for Injection in Healthy Chinese Subjects After Single and Multiple Administration

StatusCompleted
PhasePhase 1
Started2025-10-30
View on ClinicalTrials.gov ↗

Amendment history

2026-09-04
Study Status, Study Design, Contacts/Locations v1
Trial completed
Final enrollment: 12 participants (planned 42)
Primary completion dateestimated 2026-02→confirmed 2026-01-09
Completion dateestimated 2026-02→confirmed 2026-01-09
Enrollment targetestimated 42→confirmed 12
Study sitesdetails revised at 1 of 1 site
2025-11-14
Original filing
This study mainly evaluated the safety and tolerability, as well as the pharmacokinetic characteristics, of the injectable drug HRS-2183 after single and multiple administrations in healthy subjects.
Trial Details
NCT Number NCT07232758
Lead Sponsor Jiangsu HengRui Medicine Co., Ltd.
Conditions Chinese Healthy Adult Subjects
Enrollment 12 participants
Start Date 2025-10-30
Primary Completion 2026-01-09 (estimated)
Study Completion 2026-01-09 (estimated)
Updated on ClinicalTrials.gov 2026-09-08